• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于预期库尔贝克-莱布勒散度的前瞻性HIV临床试验比较。

Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.

作者信息

Cannon LaMont, Garcia Cesar Augusto Vargas, Piovoso Michael J, Zurakowski Ryan

机构信息

University of Delaware Biomedical Engineering Department, Newark, DE 19716, USA.

University of Delaware Electrical and Computer Engineering Department Newark, DE 19716, USA.

出版信息

Proc Am Control Conf. 2016 Jul;2016:1295-1300. doi: 10.1109/ACC.2016.7525096.

DOI:10.1109/ACC.2016.7525096
PMID:29332991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5761735/
Abstract

The sample frequency and volume of blood that can be drawn from a single patient is meticulously restricted under the human subject protection protocols established by an institutional review board (IRB). Consequently, the amount of samples that can be taken during a particular experiment is limited. In order to ensure an effective experiment design, considerations must be taken choosing when to take patient samples. A validated model of HIV-1 viral replication and 2-LTR production is exploited to find sub-optimal sampling schedules that maximize information content of the experiment outcome. This is done through a Forward Stepwise Regression (FSR) process with Kullback Liebler Divergence (KLD) as a selection criterion. Suboptimal schedules are found for an experiment taking four sample points over a possible span of 20 weeks. All schedules found with the FSR process contain significantly more information than both a uniform schedule and a schedule used in a previous experiment with 4 sample points. This work demonstrates the advantages of using KLD as a tool in the experiment design process to increase information content.

摘要

根据机构审查委员会(IRB)制定的人体受试者保护方案,从单个患者身上抽取的血液样本频率和量受到严格限制。因此,在特定实验中可采集的样本量是有限的。为了确保有效的实验设计,在选择何时采集患者样本时必须加以考虑。利用经过验证的HIV-1病毒复制和2-LTR产生模型来寻找次优采样方案,以使实验结果的信息含量最大化。这是通过以库尔贝克-莱布勒散度(KLD)为选择标准的前向逐步回归(FSR)过程来完成的。对于在可能长达20周的时间内采集四个样本点的实验,找到了次优方案。通过FSR过程找到的所有方案所包含的信息都明显多于均匀方案和先前一个有4个样本点的实验中所使用的方案。这项工作证明了在实验设计过程中使用KLD作为工具来增加信息含量的优势。

相似文献

1
Prospective HIV Clinical Trial Comparison by Expected Kullback-Leibler Divergence.基于预期库尔贝克-莱布勒散度的前瞻性HIV临床试验比较。
Proc Am Control Conf. 2016 Jul;2016:1295-1300. doi: 10.1109/ACC.2016.7525096.
2
Implications of Measurement Assay Type in Design of HIV Experiments.测量分析类型在HIV实验设计中的影响
Proc IEEE Conf Decis Control. 2017 Dec;2017:4106-4111. doi: 10.1109/CDC.2017.8264262. Epub 2018 Jan 23.
3
Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design.在HIV 2-LTR实验设计中,使用多元先验分布的无迹变换近似来保持预期信息内容的顺序。
Proc IEEE Conf Decis Control. 2016 Dec;2016:5597-5602. doi: 10.1109/CDC.2016.7799129.
4
Applications of a Kullback-Leibler Divergence for Comparing Non-nested Models.用于比较非嵌套模型的库尔贝克-莱布勒散度的应用。
Stat Modelling. 2013 Dec;13(5-6):409-429. doi: 10.1177/1471082X13494610.
5
A Generic Formula and Some Special Cases for the Kullback-Leibler Divergence between Central Multivariate Cauchy Distributions.中心多元柯西分布之间库尔贝克-莱布勒散度的通用公式及一些特殊情况。
Entropy (Basel). 2022 Jun 17;24(6):838. doi: 10.3390/e24060838.
6
A Kullback-Leibler Divergence for Bayesian Model Diagnostics.用于贝叶斯模型诊断的库尔贝克-莱布勒散度。
Open J Stat. 2011 Oct;1(3):172-184. doi: 10.4236/ojs.2011.13021.
7
Fault detection in the distillation column process using Kullback Leibler divergence.使用库尔贝克-莱布勒散度检测精馏塔过程中的故障。
ISA Trans. 2016 Jul;63:394-400. doi: 10.1016/j.isatra.2016.03.006. Epub 2016 Mar 25.
8
The AIC criterion and symmetrizing the Kullback-Leibler divergence.赤池信息准则与对称化库尔贝克-莱布勒散度
IEEE Trans Neural Netw. 2007 Jan;18(1):97-106. doi: 10.1109/TNN.2006.882813.
9
HIV 2-LTR experiment design optimization.HIV 2-LTR 实验设计优化。
PLoS One. 2018 Nov 8;13(11):e0206700. doi: 10.1371/journal.pone.0206700. eCollection 2018.
10
Analysis of Cell Signal Transduction Based on Kullback-Leibler Divergence: Channel Capacity and Conservation of Its Production Rate during Cascade.基于库尔贝克-莱布勒散度的细胞信号转导分析:级联过程中的通道容量及其产生率的守恒
Entropy (Basel). 2018 Jun 5;20(6):438. doi: 10.3390/e20060438.

引用本文的文献

1
Kullback-Leibler Divergence of an Open-Queuing Network of a Cell-Signal-Transduction Cascade.细胞信号转导级联开放排队网络的库尔贝克-莱布勒散度
Entropy (Basel). 2023 Feb 10;25(2):326. doi: 10.3390/e25020326.
2
Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction.表皮生长因子受体级联优先最大化信号转导。
Sci Rep. 2022 Oct 10;12(1):16950. doi: 10.1038/s41598-022-20663-0.
3
Analysis of Cell Signal Transduction Based on Kullback-Leibler Divergence: Channel Capacity and Conservation of Its Production Rate during Cascade.

本文引用的文献

1
Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.拉替拉韦强化治疗治疗后 2 长末端重复环增加和 D-二聚体减少:一项随机、安慰剂对照试验。
J Infect Dis. 2013 Nov 1;208(9):1436-42. doi: 10.1093/infdis/jit453. Epub 2013 Aug 23.
2
Modelling HIV-1 2-LTR dynamics following raltegravir intensification.模拟拉替拉韦强化治疗后 HIV-1 2-LTR 的动态变化。
J R Soc Interface. 2013 May 8;10(84):20130186. doi: 10.1098/rsif.2013.0186. Print 2013 Jul 6.
3
HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.
基于库尔贝克-莱布勒散度的细胞信号转导分析:级联过程中的通道容量及其产生率的守恒
Entropy (Basel). 2018 Jun 5;20(6):438. doi: 10.3390/e20060438.
4
HIV 2-LTR experiment design optimization.HIV 2-LTR 实验设计优化。
PLoS One. 2018 Nov 8;13(11):e0206700. doi: 10.1371/journal.pone.0206700. eCollection 2018.
5
Implications of Measurement Assay Type in Design of HIV Experiments.测量分析类型在HIV实验设计中的影响
Proc IEEE Conf Decis Control. 2017 Dec;2017:4106-4111. doi: 10.1109/CDC.2017.8264262. Epub 2018 Jan 23.
6
Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design.在HIV 2-LTR实验设计中,使用多元先验分布的无迹变换近似来保持预期信息内容的顺序。
Proc IEEE Conf Decis Control. 2016 Dec;2016:5597-5602. doi: 10.1109/CDC.2016.7799129.
包含药物疗效和储存动力学的中断试验数据的 HIV 模型参数估计。
PLoS One. 2012;7(7):e40198. doi: 10.1371/journal.pone.0040198. Epub 2012 Jul 16.
4
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.抗逆转录病毒疗法将血浆中的HIV-1 RNA抑制到由治疗前病毒血症预测的稳定水平。
PLoS Pathog. 2007 Apr;3(4):e46. doi: 10.1371/journal.ppat.0030046.
5
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.接受联合抗逆转录病毒治疗且病毒载量检测不到的儿童中持续产生1型药物敏感型人类免疫缺陷病毒。
J Virol. 2004 Jan;78(2):968-79. doi: 10.1128/jvi.78.2.968-979.2004.
6
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression.在病毒得到持续抑制的患者中,停止治疗后,高效抗逆转录病毒治疗(HAART)前的HIV负担接近HAART后的病毒水平。
AIDS. 2000 Jul 7;14(10):1357-63. doi: 10.1097/00002030-200007070-00008.
7
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.既往病毒储存库与高效抗逆转录病毒治疗中断后血浆病毒血症再次出现之间的关系。
Nat Med. 2000 Jul;6(7):757-61. doi: 10.1038/77481.
8
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.有持续病毒抑制史的患者在高效抗逆转录病毒治疗(HAART)中断后HIV-1与T细胞动力学
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15109-14. doi: 10.1073/pnas.96.26.15109.
9
Re-emergence of HIV after stopping therapy.停止治疗后HIV的再次出现。
Nature. 1999 Oct 28;401(6756):874-5. doi: 10.1038/44755.
10
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.接受抑制性高效抗逆转录病毒治疗的患者血浆中的残留HIV-1 RNA
JAMA. 1999 Nov 3;282(17):1627-32. doi: 10.1001/jama.282.17.1627.